Rubino v. Lackawann County

CourtDistrict Court, M.D. Pennsylvania
DecidedAugust 10, 2022
Docket3:18-cv-01211
StatusUnknown

This text of Rubino v. Lackawann County (Rubino v. Lackawann County) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rubino v. Lackawann County, (M.D. Pa. 2022).

Opinion

UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF PENNSYLVANIA AUTUMN (BRIAN) RUBINO, : CIVIL ACTION NO. 3:18-CV-1211 Plaintiff, : (JUDGE MARIANI) v. . LACKAWANNA COUNTY, et al., Defendants.

MEMORANDLIM OPINION |. INTRODUCTION Presently before the Court is Defendants Correctional Care, Inc. a/k/a Correctional Care, PC’s and Dr. Edward Zaloga’s Motion for Summary Judgment Pursuant to Federal Rule of Civil Procedure 56 (Doc. 48). With the Motion, Defendants Correctional Care, Inc. (“CCI”) and Zaloga (“Defendants”) seek summary judgment in their favor on all remaining claims against them contained in Plaintiffs Complaint (Doc. 1). Plaintiff filed the Complaint following a four-month incarceration at Lackawanna County Prison based on the denial of medication she had been prescribed to treat gender dysphoria. (/d. 28-57.) For the

reasons that follow, Defendants’ Motion will be granted in part and denied in part. Il. BACKGROUND Plaintiffs claims against Defendants CCI and Zaloga arise from events which occurred while Plaintiff was incarcerated at the Lackawanna County Prison beginning on

January 9, 2018, as both a pretrial and post-trial detainee.’ (Doc. 1 { 2.) Prior to her incarceration, Plaintiff alleges that she had been diagnosed with gender dysphoria by counselor Susan Decker in 2017 and was subsequently treated based on that diagnosis by CRNP Lorraine Bock at Alder Health Services. (Doc. 63 at 6 (citing Pl.’s Dep. (Pl.’s Ex. A) at 22, Doc. 62-1).) She states that hormone therapy began in approximately July 2017. □□□□ (citing Pl.’s Dep. at 33-34).) Plaintiff explains that she is a transgender female who was born with male genitalia and given the name Brian Rubino at birth. Plaintiff suffers from Gender Dysphoria. (Exhibit G at 3). Gender Dysphoria is a psychiatric diagnosis under the DSM V in which a person experiences distress because the gender that they were assigned at birth does not match the gender with which they identify. (Exhibit B at 6, p. 24; Exhibit G at 1). “Gender identity disorder’ and “Gender Dysphoria” are two names for the same condition. (Exhibit B at 11. p. 44, Exhibit D at 135). Gender Dysphoria must be diagnosed by a mental health professional. (Exhibit D at 16). However, Gender Dysphoria is required to be treated both psychiatrically and physically. (Exhibit B at 8-9, pp. 32-33; Exhibit D at 15). Treatments include, but are not limited to, hormone therapy, counseling, and surgery. (Exhibit B at 9, p. 33). Medical doctors, rather than mental health professionals, provide the hormone therapy and surgery once a diagnosis is made. Treatment for Gender Dysphoria is medically necessary. (Exhibit C at 5, p. 20; Exhibit D at 19; Exhibit G at 2). Gender Dysphoria is a serious medical need, and the alteration of treatment can cause physiological changes and psychological harm. (Exhibit G at 2-3). Specifically, the cessation of hormones can be devastating to a patient. (Exhibit G at 2). (Doc. 63 at 5.) At the time of her incarceration, Plaintiff told Lackawanna County medical personnel that she was transitioning from male to female. (/d. at 6 (citing Zaloga Dep. (PI.’s Ex. B) at

1 Plaintiff does not elaborate on her status. (See Doc. 78 at 17.)

50, Doc. 62-1; Ex. H at 024, Doc. 62-8).) Plaintiff also told medical personnel that she had been taking prescribed hormone medications and requested that they be continued. (/d.) After Plaintiff again requested the hormone medications on January 13, 2018, CRNP Anthony lannuzzi noted that Plaintiff had been prescribed Estardiol and Aldacterone for transitioning and he requested hormone medication for her. (Zaloga Dep. 41:3-9, Doc. 63- 2.) Dr. Zaloga overruled CRNP lannuzzi’s order, noting that “[t}hese are non-life-sustaining medications which have not been FDA approved for the requested purpose whose risks of serious and potentially fatal side effects far outweigh any subjective benefits.” (/d. 42:7-15.) On January 15, 2018, Plaintiff submitted an inmate request form, which she identified as a “grievance”, stating that “I was turned down by doctor to getting my hormones Estroden [sic]1.5 mg as required by my Doctor Lorraine Brock Alder Health Services. | am federally have the fight to continue my treatment.” (Doc. 49-2 at 2; Doc. 49 J 5; Doc. 62 { 5.) The request/grievance was forwarded to the Medical Department on January 19, 2018, and responded to on January 29, 2019. (Doc. 49 4 50; Doc. 62 50.) The response states: 1. Estrogen is not “required,” you want it; you don’t need it. 2. Lorraine Brock is not a doctor. 3. You don’t have the “right” to elective treatment. 4, In my professional medical opinion, the risks far outweigh any subjective benefits. (Doc. 49-2 at 2.)

Plaintiff submitted a second inmate request form on January 15, 2018, again asking to be given hormone medication. (Doc. 49 J 7; Doc. 62 J 7.) In his January 23, 2018, response, Dr. Zaloga stated that, in his professional medical opinion, “the risks of serious adverse effects, including possible stroke & death, far outweigh any subjective benefit [and] [e]strogen is not F.D.A. approved for this purpose, therefore it would be considered experimental.” (Zaloga Dep. 42:11-14, Doc. 62-2; see also Doc. 49 J 9; Doc. 62 { 9.) Although Plaintiff agrees that this is Dr. Zaloga’s response to his request, and that the use is not F.D.A. approved, she asserts that “the medications are ordinarily used as off-label uses to treat gender-dysphoria in the medical field.” (Doc. 62 {9 (citing Zaloga Dep. at 42-43, Doc. 62-2; lannuzzi Dep. (PI.’s Ex. D) at 133, Doc. 62-4; Fleetman Dep. (PI.’s Ex. F) 17:62- 63, Doc. 62-6).) On January 25, 2018, Plaintiff submitted another inmate request form, stating that she wanted to see “the head doctor of this prison about not giving me my estrogen and spirolactone or | will report this to my federal PD and take it to the court.” (Doc. 49-4 at 2.) The response stated “1. Previously asked & answered. There is nothing to talk about[.] 2. Proceed as you feel appropriate.” (/d.) Defendants requested and received records from previous treating providers. (Doc. 49 J 12; Doc. 62 | 12.) Geisinger records did not include an evaluation or diagnosis of gender dysphoria. (Doc. 49 | 12; Doc. 62 J 12.) However, Plaintiff asserts that his last treatment at Geisinger was on April 3, 2017, and his subsequent treatment at Alder Health

Services is where she was diagnosed and began hormone therapy treatment. (Doc. 62 12 (citing Bock Dep. (PI.’s Ex. E) at 28, 41, Doc. 62-5; Ex. H at 117-118, Doc. 62-8).) She further asserts that CVS Pharmacy confirmed the valid prescriptions for the hormone medications. (/d. (citing Ex. H at 009).) Alder Health records “initially include the following ‘problems’: disorder of the endocrine system, schizoaffective disorder, bipolar disorder, developmentally disabled, and tachycardia.” (Doc. 49 16 (citing Defs.’ Ex. F, Doc. 48-6).) Defendants add that 17. The Alder Health records also note prescriptions for, inter alia, hormone treatment medications estradiol and spironolactone. /d. 18. The records show that Plaintiff was first seen at Alder Health on November 22, 2016. Id. 19. At that time she was seen by Nurse Practitioner Lorraine Bock. /d. 20. The reason for visit section of the note states that “Pt is here for HRT to transition from Male to Female. States has a therapist named Susan Decker in Williamsport at Diakon. We have not gotten any information from her yet.” /d. 21. At the end of the visit, Plaintiff was instructed to “contact therapist & get letter. Needs to begin living in his preferred gender.” /d. 22. Plaintiff was diagnosed, at that time, with a disorder of the endocrine system, for which she was prescribed estradiol and prolactin. /d. 23.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Bell v. Wolfish
441 U.S. 520 (Supreme Court, 1979)
City of Revere v. Massachusetts General Hospital
463 U.S. 239 (Supreme Court, 1983)
Malley v. Briggs
475 U.S. 335 (Supreme Court, 1986)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. National Wildlife Federation
497 U.S. 871 (Supreme Court, 1990)
Brosseau v. Haugen
543 U.S. 194 (Supreme Court, 2004)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Giles v. Kearney
571 F.3d 318 (Third Circuit, 2009)
Gonzalez v. AMR
549 F.3d 219 (Third Circuit, 2008)
United States v. Michener
152 F.2d 880 (Third Circuit, 1945)
Kaucher v. County of Bucks
455 F.3d 418 (Third Circuit, 2006)
Mullenix v. Luna
577 U.S. 7 (Supreme Court, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Rubino v. Lackawann County, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rubino-v-lackawann-county-pamd-2022.